For instance, AChE inhibitors offer relatively short-lasting positive effects in AD patients [151] and display cholinomimetic actions on the gastrointestinal tract that result in diarrhea, nausea, and vomiting [152]. The gene discussed is ACHE; the disease is Alzheimer disease.